Mitsui Global Investment
Venture capitalMenlo Park · Pre-Seed–Late Stage · 14 people tracked
Also known as MITSUI & CO. GLOBAL INVESTMENT, INC. · Mitsui & Co. Global Investment, Inc. 東京支店
Investment thesis
The firm positions itself as an investor that goes beyond financial backing, actively guiding entrepreneurs with strong business plans and ambitious goals. It partners with exceptional teams reinventing industries to improve human welfare worldwide, and emphasizes involvement in local communities alongside a global growth orientation. The firm highlights portfolio companies that have overcome setbacks and market challenges to grow stronger.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & public directories
What they invest in
from 13 of 62 portfolio companiesBiotech ×6AI & Machine Learning ×3Deep Tech ×3Cleantech ×2Data & Infrastructure ×2Digital Health ×2Enterprise Software ×2Advanced Manufacturing ×1
HQs:United States×16
Investments · 62 tracked
founders shown can be your intro pathBiopharmaceutical company developing therapeutics for respiratory and inflammatory disorders such as asthma and rheumatoid arthritis.
BiotechSan Mateo, US
Fred Middleton(Director)Peter McWilliams(Executive Officer, Director)Kevin Bacon(Executive Officer, Director)
BoardMasaji Matsuoka(Director)
BiotechCalabasas, US
Ruben Boado(Executive Officer)William Pardridge(Director)Jayson Punwani(Director)Mathias Schmidt(Executive Officer, Director)Martin Heidecker(Director)
Prior team investment; acquired by Broadcom.
Biotech developing novel cancer therapeutics targeting cancer stem cells.
San Francisco, US
Darren Hite(Director)Jae Chung(Executive Officer, Director)Masashi Kiyomine(Director)Sujay Jadhav(Executive Officer, Director)Lawrence Low(Director)
San Diego, US
BiotechSouth San Francisco, US
Yael Weiss(Executive Officer, Director)
BoardCamille Samuels(Director)Marten Steen(Director)Shalini Sharp(Director)Stephen Farr(Director)
AgTechDavis, US
Pamela G. Marrone(Executive Officer, Director)James B. Boyd(Executive Officer)Pamela Contag(Director)Richard Rominger(Director)George Kerckhove(Director)Linda V. Moore(Executive Officer)
Company improving human health through digital healthcare solutions using ultra-thin flexible body-worn sensors and advanced analytics.
Lexington, US
Alice Sansone(Executive Officer)Marc Singer(Director)Jiong Ma(Director)Paul Klingenstein(Director)Carmichael Roberts(Director)John Rogers(Director)
Burlingame, US
Neura Health provides telemedicine video visits with board-certified neurologists for conditions including migraine, epilepsy, sleep disorders, tremor, concussion, and stroke.
Digital HealthHealthtechNew York, US
Maple Grove, US
Michael Hoey(Executive Officer, Director)Patrick Fabian(Executive Officer)Andre de Bruin(Director)Tom Lowe(Director)Glen Nelson(Director)Maximillian Fiore(Executive Officer)
Proterra designs and manufactures zero-emission battery systems for commercial vehicles.
CleantechHardwareMobility & TransportationGreenville, US
Ryan Popple(Executive Officer, Director)Eric McCarthy(Executive Officer)Rob Johnson(Director)Michael Smith(Director)Tom von Reichbauer(Director)Mike Donoughe(Director)
Semiconductor laser application products including eyewear for low-vision users and silicon photonics.
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)Roet(Co-founder)Woolf(Co-founder)Laia Crespo-Martin(Director)Shafique Virani(Executive Officer)Johannes Fruehauf(Director)
Reunion develops serotonergic psychedelic therapies for mental health conditions, targeting postpartum depression, adjustment disorder, and generalized anxiety disorder.
BiotechDigital HealthMental HealthMorristown, US
Sahil V. Kirpekar(President and CEO)Gregory Mayes(Executive Officer, Director)Michael Ehlers(Director)Ansbert Gadicke(Director)Natalie Sacks(Director)Ellen Lubman(Director)
Streamlines hospital and industry data collaborations for AI in healthcare without compromising data privacy.
Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.
AI & Machine LearningData & InfrastructureEnterprise Software
Dr. Ittai Dayanin
Focuses on discovery and clinical development of targeted cancer drugs.
Sirrus develops chemical building blocks based on patented methylene malonate monomers and oligomeric crosslinkers that polymerize anionically at ambient temperatures.
Advanced ManufacturingCleantechDeep TechNew MaterialsLoveland, US
Doug Cameron(Director)John Trbovich(Director)Robert Pangborn(Director)Adam Malofsky(Director)John Habbert(Assistant Secretary)Kieran Drain(Director)
Spire operates a constellation of nanosatellites that collect granular Earth and environmental data from orbit, providing analytics for climate, logistics, and community protection.
Climate TechData & InfrastructureLogistics & Supply ChainSpace TechVienna, Virginia, US
Peter Platzer(Founder)inJeroen Cappaert(Founder)inJoel Spark(Founder)
Frequently asked questions
- What stage does Mitsui Global Investment invest at?
- Mitsui Global Investment invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Mitsui Global Investment's typical check size?
- Mitsui Global Investment typically writes checks of $500K – $10M.
- What sectors does Mitsui Global Investment focus on?
- Mitsui Global Investment focuses on AI & Machine Learning, Biotech, Cleantech, Consumer, Data & Infrastructure, Energy, Enterprise Software, FoodTech, Hardware, Healthtech, Medical Devices, New Materials, SaaS, Sector Agnostic, Semiconductors.
- Where is Mitsui Global Investment located?
- Mitsui Global Investment is headquartered in Menlo Park, US.
Images
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Chuangdongfang (创东方) is a Shenzhen-based investment firm focused on equity investment in technology and innovation-driven enterprises, engaging in venture, M&A, and industrial investment.
SBI Investment Korea is a Korean asset management firm within the SBI Group that operates venture capital and private equity funds, positioning itself as a 'New Industry Creator'.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.